» Articles » PMID: 12185249

The Program of Androgen-responsive Genes in Neoplastic Prostate Epithelium

Overview
Specialty Science
Date 2002 Aug 20
PMID 12185249
Citations 195
Authors
Affiliations
Soon will be listed here.
Abstract

The human prostate gland is an important target organ of androgenic hormones. Testosterone and dihydrotestosterone interact with the androgen receptor to regulate vital aspects of prostate growth and function including cellular proliferation, differentiation, apoptosis, metabolism, and secretory activity. Our objective in this study was to characterize the temporal program of transcription that reflects the cellular response to androgens and to identify specific androgen-regulated genes (ARGs) or gene networks that participate in these responses. We used cDNA microarrays representing about 20,000 distinct human genes to profile androgen-responsive transcripts in the LNCaP adenocarcinoma cell line and identified 146 genes with transcript alterations more than 3-fold. Of these, 103 encode proteins with described functional roles, and 43 represent transcripts that have yet to be characterized. Temporal gene expression profiles grouped the ARGs into four distinct cohorts. Five uncharacterized ARGs demonstrated exclusive or high expression levels in the prostate relative to other tissues studied. A search of available DNA sequence upstream of 28 ARGs identified 25 with homology to the androgen response-element consensus-binding motif. These results identify previously uncharacterized and unsuspected genes whose expression levels are directly or indirectly regulated by androgens; further, they provide a comprehensive temporal view of the transcriptional program of human androgen-responsive cells.

Citing Articles

Decoding the epigenetics and chromatin loop dynamics of androgen receptor-mediated transcription.

Altintas U, Seo J, Giambartolomei C, Ozturan D, Fortunato B, Nelson G Nat Commun. 2024; 15(1):9494.

PMID: 39489778 PMC: 11532539. DOI: 10.1038/s41467-024-53758-5.


Inhibitors of the transactivation domain of androgen receptor as a therapy for prostate cancer.

Obst J, Tien A, Setiawan J, Deneault L, Sadar M Steroids. 2024; 210:109482.

PMID: 39053630 PMC: 11364166. DOI: 10.1016/j.steroids.2024.109482.


R-loop resolution by ARIP4 helicase promotes androgen-mediated transcription induction.

Ng R, Lin Z, Zhang Y, Ti S, Javed A, Wong J Sci Adv. 2024; 10(29):eadm9577.

PMID: 39028815 PMC: 11259169. DOI: 10.1126/sciadv.adm9577.


DHCR24 in Tumor Diagnosis and Treatment: A Comprehensive Review.

Fu X, Wang Z Technol Cancer Res Treat. 2024; 23:15330338241259780.

PMID: 38847653 PMC: 11162140. DOI: 10.1177/15330338241259780.


Androgen Signaling in Prostate Cancer: When a Friend Turns Foe.

Pandey S, Sabharwal U, Tripathi S, Mishra A, Yadav N, Dwivedi-Agnihotri H Endocr Metab Immune Disord Drug Targets. 2024; 25(1):37-56.

PMID: 38831575 DOI: 10.2174/0118715303313528240523101940.


References
1.
Nelson P, Han D, Rochon Y, Corthals G, Lin B, Monson A . Comprehensive analyses of prostate gene expression: convergence of expressed sequence tag databases, transcript profiling and proteomics. Electrophoresis. 2000; 21(9):1823-31. DOI: 10.1002/(SICI)1522-2683(20000501)21:9<1823::AID-ELPS1823>3.0.CO;2-3. View

2.
Perry J, Tindall D . Androgens regulate the expression of proliferating cell nuclear antigen posttranscriptionally in the human prostate cancer cell line, LNCaP. Cancer Res. 1996; 56(7):1539-44. View

3.
Prins G . Molecular biology of the androgen receptor. Mayo Clin Proc. 2000; 75 Suppl:S32-5. View

4.
Akoulitchev S, Chuikov S, Reinberg D . TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature. 2000; 407(6800):102-6. DOI: 10.1038/35024111. View

5.
Bonkhoff H, Remberger K . Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate. 1996; 28(2):98-106. DOI: 10.1002/(SICI)1097-0045(199602)28:2<98::AID-PROS4>3.0.CO;2-J. View